Sartorius AG
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Michael Grosse
- Full Time Employees
- 14,042
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Otto-Brenner-Strasse 20 Goettingen NI Germany 37079
- IPO Date
- Apr 1, 1999
- Website
- sartorius.com
- Similar Companies
- Business
- Sartorius AG operates as a premier international supplier of laboratory equipment and bioprocess technology, headquartered in Göttingen, Germany, and serving the global life science research and biopharmaceutical sectors. The company empowers scientists and engineers through its comprehensive offerings, aimed at accelerating progress and simplifying complex workflows, ultimately enabling the development of advanced therapies and more accessible medicine. The organization is structured around two principal divisions: Bioprocess Solutions and Lab Products & Services. The Bioprocess Solutions segment delivers an extensive portfolio encompassing the entire biopharmaceutical production chain, from initial cell line development through to final purification and fluid management. This includes advanced biosensors, label-free detection platforms, and cell analysis systems, alongside a wide array of cell culture media and reagents for antibody, viral vaccine, regenerative medicine, and stem cell applications. Further, it provides multi-parallel, benchtop, single-use, and stainless steel bioreactors for cell culture and microbial fermentation, complete with associated software. The division also specializes in filtration products such as membranes, blotting media, syringe filters, and ultrafiltration and sterile filtration devices, in addition to advanced process chromatography solutions and comprehensive fluid management systems. The Lab Products & Services division furnishes research and quality control laboratories within pharmaceutical, biopharmaceutical, chemical, and food industries, as well as academic institutions, with essential instruments and consumables. Its offerings span high-precision laboratory balances, sophisticated pipetting and dispensing systems, and state-of-the-art laboratory water purification units. This segment also includes analytical tools like flow cytometry platforms and live-cell analysis systems, industrial microbiology solutions, and centrifuges. Beyond products, Sartorius offers critical services such as bioprocess development and engineering, biologics testing, and instrument validation. With a focus on single-use technologies and a razor/blade business model, the company generates significant recurring revenue through consumables, being "spec'd in" for regulatory approvals, which provides a long-term revenue stream for approved products. Recent strategic developments include a 2025 partnership with Tulip Interfaces to integrate automation solutions and the acquisition of MatTek, including Visikol Inc., to bolster capabilities in human cell-based microtissues for preclinical drug development. In 2024, Sartorius also entered a collaboration with Sanofi to commercialize a platform for integrated and continuous downstream bioprocessing. Founded in 1870, Sartorius maintains its global operations from its headquarters in Göttingen, Germany.
Company News
Sartorius Aktiengesellschaft (OTCMKTS:SOAGY) Stock Short Interest Rises 322.6%
Sartorius Aktiengesellschaft (SOAGY) Q2 2026 Earnings Call Transcript
Reviewing Integra LifeSciences (NASDAQ:IART) & Sartorius (OTCMKTS:SARTF)
Sartorius Aktiengesellschaft (SOAGY) Analyst/Investor Day Transcript
Sartorius Aktiengesellschaft (SOAGY) Q4 2025 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCMKTS:SOAGY) Short Interest Update
Critical Survey: ClearPoint Neuro (NASDAQ:CLPT) vs. Sartorius (OTCMKTS:SARTF)
Sartorius: Consistent Performance And Market Resurgence - Valuation Falls
7 Stocks Taking The Next Step To Be On Offense
Sartorius Aktiengesellschaft (SOAGY) Q3 2025 Earnings Call Transcript
Sartorius Aktiengesellschaft (SARTF) Q2 2025 Earnings Call Transcript
Sartorius Aktiengesellschaft (SARTF) Q1 2025 Earnings Call Transcript
Sartorius Aktiengesellschaft (SARTF) Q4 2024 Earnings Call Transcript
Sartorius Aktiengesellschaft (SARTF) Q3 2024 Earnings Call Transcript
Sartorius Aktiengesellschaft (SARTF) Q1 2024 Earnings Call Transcript
SARTORIUS (SARTF) Upgraded to Strong Buy: Here's What You Should Know
Sartorius Aktiengesellschaft (SARTF) Q4 2023 Earnings Call Transcript
10 stocks for investors looking for ‘wonderful companies at a fair price'
SARTORIUS (SARTF) Q3 Earnings Lag Estimates
Sartorius Aktiengesellschaft (SARTF) Q2 2023 Earnings Call Transcript